Quiz|Articles|January 25, 2026
Dermatology Times Spot Test: January 25, 2026
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- The conference highlighted innovative treatments and emerging technologies in dermatology, offering insights into cutting-edge therapies and diagnostic tools.
- Attendees discussed the implications of recent advancements on clinical practice, emphasizing the importance of staying informed about ongoing research.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Welcome to Dermatology Times' Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. In this edition, we'll cover some highlights from this year’s
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
In his presentation, “What’s New in the Medicine Chest,” James Del Rosso, DO, highlighted solifenacin gel 12.45%, which is approved for the treatment of what condition?
The INTEGUMENT-PED subgroup analysis poster presented at Winter Clinical Hawaii primarily evaluated what?
As Del Rosso noted, what is the primary mechanism of action of berdazimer gel?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement